Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells-Reference-Cited by-同舟云学术

Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells

Published:2012-06-29 Issue:6 Volume:7 Page:e40195
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bowlby Sarah C.,Thomas Michael J.,D’Agostino Ralph B.,Kridel Steven J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. Nicotinate Phosphoribosyltransferase of Yeast.;A Kosaka;Journal of Biological Chemistry,1971

2. Enzymatic Synthesis of Nicotinamide Mononucleotide.;J Preiss;Journal of Biological Chemistry,1957

3. FK866, a Highly Specific Noncompetitive Inhibitor of Nicotinamide Phosphoribosyltransferase, Represents a Novel Mechanism for Induction of Tumor Cell Apoptosis.;M Hasmann;Cancer Res,2003

4. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.;A Le;Proceedings of the National Academy of Sciences,2010

5. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival.;H Yang;Cell,2007

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NAD+ metabolism: dual roles in cancer treatment;Frontiers in Immunology;2023-12-05

2. Neuromuscular electrical stimulation enhances the ability of serum extracellular vesicles to regenerate aged skeletal muscle after injury;Experimental Gerontology;2023-06

3. Pyruvate Dehydrogenase Inhibition Leads to Decreased Glycolysis, Increased Reliance on Gluconeogenesis and Alternative Sources of Acetyl-CoA in Acute Myeloid Leukemia;Cancers;2023-01-12

4. Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer;Cancers;2022-12-06

5. Cellular and molecular insights into the roles of visfatin in breast cancer cells plasticity programs;Life Sciences;2022-09